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Summary Sleep is the most conspicuous alteration of cerebral function during the circadian
rhythm. It is composed of a cyclic sequence of stages deﬁned on the basis of electrophys-
iological parameters. The underlying functional activity of the human brain is reﬂected by
sleep correlated changes of cerebral blood ﬂow (CBF), CBF velocity and cerebral metabolism
(CM). Transcranial Doppler sonography (TCD) allows to analyze the rapid adaptation processes
of cerebral hemodynamics due to TCD capabilities for high temporal resolution and continu-
ous recording during sleep using modern ultrasonic probes with special ﬁxation devices. After
the onset of sleep there is a signiﬁcant progressive reduction of CBF velocity from the waking
state to slow wave sleep. The beginning of REM sleep is accompanied by a marked increase in
CBF velocity. Furthermore, TCD enables the assessment of perfusion changes in pathologicalsyndrome
sleep conditions. In sleep apnea syndrome an apnea-associated increase in CBF velocity occurs,
which is attributed to apnea-related hypercapnia, whereas a rapid normalization of ﬂow veloc-
ity occurs at the end of each apneic episode. TCD is a useful method for long-term and on-line
monitoring of dynamic changes in cerebral perfusion during normal sleep and in sleep disorders.
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Cerebral electrical activity, CBF and CM during
normal sleep
The two basic types of sleep are non-rapid eye movement
(NREM) and rapid eye movement (REM) sleep. In humans
NREM sleep is further subdivided into four stages, each asso-
ciated with distinct states of altered consciousness [1,2].
When compared with baseline levels during wakefulness,
cerebral blood ﬂow (CBF) and cerebral metabolism (CM)
decrease with the onset of sleep and during sleep stages land
I—II and reach minimum values in all brain regions during
slow-wave sleep (SWS; sleep stages III and IV) [3—10]. These
changes are not uniformly distributed. Against this global
Openfall in CBF are important regional variations with some brain
regions (frontal cortex, basal ganglia, thalamus, pons, cere-
bellum) affected to a greater degree while others (temporal
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Open access under CC BY-NC-ND license.ortex) are relatively affected to a minor degree [7,11]. CBF
nd CM rise to or even exceed waking levels during rapid eye
ovement (REM) sleep [3,4,6,11—14]. In a study of regional
BF during REM sleep, Madsen et al. [15] showed that during
EM sleep CBF increases in the associative visual area while
t decreases in the inferior frontal cortex.
Electroencephalography studies show that there is a
yperfrontal distribution of the electrical activity of the
rain during wakefulness [16]. The electroencephalogram
EEG) pattern is closely coupled with the state of con-
cious awareness. With increasing depth of sleep [17], this
egional differentiation is lost and the EEG shows a gen-
ralized decrease of frequency. During REM sleep, high
ixed frequencies occur [2,18]. A close correlation between
he EEG frequency, CBF and CM during human sleep has
een reported [7,16,19,20], corroborating the notion of a
s under CC BY-NC-ND license.ight coupling between cerebral electrical activity, CBF and
M [21—25]. The changes in EEG frequency, CBF and CM
ave been attributed to variations of brain activity during
leep.
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Figure 1 Relative mean ﬂow velocities (related to the evening
wakefulness values, W) detected in the middle cerebral artery
(MCA). Black bars = left MCA, n = 16. Hatched bars = right MCA,
n = 18. (A) During different NREM sleep stages (1st and 2nd sleep
cycle) and (B) during REM sleep, together with sleep stage II
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Transcranial Doppler sonography (TCD) allows continuous
easurement of CBF velocity in the major cerebral arter-
es and with TCD the rapid adaptation processes of cerebral
emodynamics that occur during sleep may be analyzed with
high temporal resolution [26—29].
Ever since the beginning of clinical sleep research, the
esults of electroencephalographic recordings of the course
f sleep have contradicted the ﬁndings of radioisotope
racer studies, which were obtained during a short sam-
ling period for each sleep phase. The radioisotope studies
evealed only a static picture of CBF and CM and were
nable to demonstrate sleep as a dynamic state of changing
erebral function [3,30—32]. Because of TCD’s capabilities
or high temporal resolution and continuous recording using
odern ultrasonic probes with special ﬁxation devices, the
elationship between EEG and cerebral perfusion changes
ver the course of the entire sleep period can now be
ecorded.
BF velocity during normal sleep
n a study by Fischer et al. [33], the ﬂow velocity (FV) in
he right middle cerebral artery (MCA) was assessed during
vening wakefulness, sleep stages II or IV of non-rapid eye
ovement (NREM) sleep and the morning waking stage in 5
ealthy children (age: 5—13 years) and 6 adults (age: 24—42
ears). Polysomnography was performed in all subjects. The
FV decreased during NREM sleep by an average of 21% in the
dults and 32% in the children. An MFV increase was observed
uring awakening but, in both children and adults, the MFV
as an average 19% less than during evening wakefulness.
o signiﬁcant change in pCO2 was observed during sleep.
rom these ﬁndings, the authors concluded that the degree
f wakefulness should be taken into account when assessing
CD study ﬁndings.
In another study by this group [34], the intracranial hemo-
ynamics of sleep apnea syndrome (SAS) was assessed in
1 healthy adults (age: 37.1± 3.2 years), who served as
he control group. The study design was the same as in
he former study, except that, in this study, MFV measure-
ents were also obtained during REM sleep. In this study,
he MFV decreased by an average 17.5% during NREM sleep
nd a further slight decrease occurred in REM sleep. The
FV measured after awakening the next morning was an
verage 8.4% lower than the wakefulness value measured
n the preceding evening. Changes in the pCO2 during sleep
ere also detected in this test group; there was a 10.5%
ecrease during NREM sleep and a 3.2% decrease during
EM sleep. The pCO2 measured the next morning was 4.8%
ower than the pCO2 of the previous evening. After CO2 cor-
ection of the MFV values [35], these researchers detected
signiﬁcant MFV decrease during REM sleep and a slight
FV increase during NREM sleep compared with the values
bserved during evening wakefulness and after awakening
he next morning. This group’s ﬁndings on the MFV dynam-
cs during sleep differ from those of other research groups
36—39].Droste et al. [36], for example, obtained different results
n their study of the MFV development in the MCA during noc-
urnal sleep in 10 healthy volunteers (age: 25—31 years). The
FV was signiﬁcantly higher during REM sleep than in the
a
m
T
drior to and after REM sleep (1st and 2nd sleep cycle). MFV:
ean ﬂow velocity (according to [39]).
REM sleep stages and nocturnal wakeful states. After ana-
yzing the results of their nocturnal TCD recordings using a
ast Fourier transformation algorithm, they detected rhyth-
ic ﬂuctuations in the TCD curves, particularly during REM
leep, with wavelengths ranging from 20 to 75 s. Droste’s
roup saw a causal relationship between the rhythmic oscil-
ations and the B-waves of nocturnal intracranial pressure
ICP) ﬂuctuations.
Klingelhöfer et al. [39] measured the MFV in the
ight (n = 18) and left MCA (n = 16) as well as heart rate,
eripheral arterial blood pressure and pCO2 in 18 healthy
ale volunteers (age: 24—34 years) during two nights.
olysomnography, performed in all volunteers, included an
EG, bilateral electrooculogram, electromyogram (submen-
al and anterior tibial muscle), ECG, measurement of nasal
nd oral airﬂow during chest and abdominal wall respiratory
ovements, blood pressure, pulsoximetry and capnometry.
he MFV changes and pCO2 changes during the manually
etermined sleep stages of the ﬁrst, second and last sleep
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cycles were determined with reference to the evening wake-
fulness values (Fig. 1). For assessment of sleep events (EEG),
all sleep spindles, K-complexes with and without sleep spin-
dles, EEG arousals and movement arousals (EEG arousals
with an increase in EMG activity) during the last sleep cycle
were manually determined from polysomnograms obtained
during 12 nights and time-correlated to the corresponding
MFV values and vegetative parameters. After a total of 980
EEG events, the reactions of the MFV and autonomic nervous
system were assessed.
Long-term analysis in healthy subjects (whole
night period)
After the onset of sleep, there> was a signiﬁcant (p < 0.001)
progressive reduction of the MFV from the waking state to
stage IVa of the ﬁrst sleep cycle (Figs. 1 and 2). In spite of the
subsequent decrease in the depth of sleep, MFV decreased
further from stages IVa to IIc preceding the REM period. MFVs
in stage IIa of the second and last sleep cycles were signiﬁ-
cantly (p < 0.01) lower than those in stage IIa during the ﬁrst
NREM cycle. A special pattern in the MFV proﬁle was seen
during passage through the second and subsequent NREM
sleep cycles. MFV values were low during sleep stages IIa
and IVa following REM sleep, increased moderately during
intermediate sleep stage IIb and decreased again gradually
with consecutive sleep stages IIIb, IVb and IIc. The decrease
in MFV values was less during the second and last NREM
sleep stages than during the ﬁrst sleep cycle. MFV values
in all sleep stages did not differ signiﬁcantly during the
NREM sleep stages in the second and last NREM sleep cycles
studied.
The beginning of REM sleep was accompanied by a marked
increase in MFV. MFV values markedly exceeded values of
the preceding sleep stages II and IV but did not reach wak-
ing values in the ﬁrst, second and last sleep cycle. The
MFV during alpha-frequency wakefulness that follows NREM
Figure 2 Relative MFV in the right (n = 14) and left (n = 12)
MCA during different sleep stages in healthy male volunteers
(according to [38]).
Figure 3 Course of the MFV (relative values) of the right MCA
and the corresponding sleep proﬁle in a 26-year-old healthy
subject. Lower-case letters characterize (a) progressive MFV
reduction; (b) increased MFV during REM sleep; (c) reduced MFV
while awakening; (d) movement artifact; and (e) unaltered MFV
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iuring changes from stage II to slow-wave sleep (according to
66]).
leep was lower than waking values preceding sleep onset
Fig. 3). After morning awakening, patients lying awake
ften required more than half an hour to reach MFV values
orresponding to the waking state of the previous evening.
FV proﬁles were occasionally interrupted by movement
rtifacts in all healthy subjects (Fig. 3).
hort-term analysis in healthy subjects (dynamics
f rapid FV ﬂuctuations)
apid ﬂuctuations in FV lasting seconds occurred during
WS as well as stage II and REM sleep. Fig. 4 shows the FV
urve with corresponding sleep stages in a typical healthy
ubject [39]. There were no major ﬂuctuations of FV during
tage IV. Moderate ﬂuctuations appeared during sleep stage
I. During REM sleep, the amplitude and the duration of
uctuations were markedly increased. Large ﬂuctuations
n FV lasting seconds were accompanied by ﬂuctuations
igure 4 Dynamics of rapid FV ﬂuctuations in the left MCA
uring the transition from sleep stage IV to REM sleep via stage II
n the ﬁrst sleep cycle in a 25-year-old healthy subject (accord-
ng to [39]).
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Figure 5 Relationship between FV (right MCA), MFV, blood
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dressure, end-expiratory CO2 concentration, and sleep events
Kc, K-complex; Ar, arousal) in sleep stage II in a healthy 27-
ear-old subject (according to [39]).
n blood pressure. However, the changes in peripheral
lood pressure and pulse were not always accompanied
y corresponding changes in FV. Fluctuations in FV also
ccurred following sleep events such as K-complexes and
rousal. Immediately after the sleep event there was a
oderate increase followed by a pronounced decrease in
FV. During REM sleep, increases in velocity that appeared
uring phases of rapid eye movements (phasic REM) often
ersisted for several minutes.
Fig. 5, showing a typical recording of about 6min dura-
ion during sleep stage II, illustrates FV ﬂuctuations that
orrelated with cardiovascular and respiratory parameters.
-complexes and arousal initiated the observed alterations
n FV, MFV, blood pressure and CO2. Blood pressure increased
n the subsequent cardiac cycles, reaching a maximum after
bout 5 s, then returned to normal during the next 5—15 s.
ncreases in MFV did not always occur despite rising blood
ressure in stage II but were usually found with greater rises
f blood pressure in REM sleep. Blood pressure and MFV
urves did not follow a parallel course. Hyperventilation
ith 2—3mmHg decrease in CO2 often persisted for more
han 30 s during sleep (Fig. 5). A close correlation was found
etween decreases in MFV and reduction of CO2.
In their interpretation of these ﬁndings, the authors con-
luded that the reduction in MFV during NREM sleep is a
eﬂection of reduced cerebral activity and that the later
ncrease during REM sleep corresponds to the active brain
rocesses associated with frequent dream phases. The ﬁnd-
ngs in the ﬁrst sleep cycle are in agreement with the
esults of CBF measurements and they conﬁrm the close
elationship between cerebral perfusion and brain electrical
ctivity, even during human sleep. Continuous measurement
ver the entire sleep period, as permitted by TCD, demon-
trated that, in the later sleep cycles, the course of MFV
evelopment is independent of the NREM sleep stages. This
nding, together with the ﬁnding of delayed MFV increase
fter morning awakening, may indicate an uncoupling of
rain electrical activity from cerebral perfusion in sleep.
his suggests that other mechanisms besides locally active
echanisms may also be involved in the regulation of cere-
ral perfusion during sleep. The MFV changes after EEG
vents can be interpreted as a result of cardiovascular and
s
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espiratory reactions that occur during the waking reaction.
rimary constriction of the cerebral arteries mediated by the
ctivated sympathetic nervous system may also be hypothe-
ized. Quantitative differences in the MFV ﬂuctuations after
-complexes, EEG arousal and movement arousal correspond
o the increasing intensity of the associated awakening reac-
ions. The absence of MFV responses and autonomic nervous
ystem responses during the occurrence of sleep spindles
upport the theory that sleep spindles are sleep-protective
vents.
Droste et al. [40] studied intracranial pressure B-waves
nd their association with rhythmic changes in CBF veloc-
ty (B-wave equivalents) by TCD monitoring. In overnight
CD recordings in 10 normal young adults, these rhythmic
hanges in CBF velocity were higher and more frequent dur-
ng REM sleep and sleep stage I than during other sleep
tages. B-wave equivalents also had a longer wavelength
uring REM sleep. These results support the hypothesis that
CP B-waves are caused by vasodilation.
The MFV dynamics in the right and left MCAs of 12 healthy
olunteers (age: 25—34 years) was also studied by Hajak
t al. [38] using the same test design. The MFV values
easured during NREM sleep were lower than those
etected during wakefulness and the values measured dur-
ng the second and last sleep cycle were signiﬁcantly lower
han in the ﬁrst sleep cycle. The MFVs in sleep stage II at the
nd of an NREM sleep period were lower than in the preced-
ng slow-wave sleep. At the onset of REM sleep, the MFV
ncreased rapidly and reached a level signiﬁcantly higher
han in the preceding NREM sleep period. MFV ﬂuctuations
ccurred in all sleep stages; the most signiﬁcant ﬂuctuations
ccurred during REM sleep and the least pronounced ﬂuctu-
tions were observed in slow-wave sleep. In the later sleep
ycles, the MFV changes from one sleep stage to another
ere less pronounced than in the ﬁrst sleep cycle. During
he transition from NREM sleep to wakefulness, the MFV
emained lower than in the evening pre-sleep stage. Even
fter the patients awoke the next morning, it took several
inutes for the MFV to reach the value measured during
he pre-sleep phase of the previous evening. There were
o signiﬁcant side-to-side differences between the left and
ight MCA. When changes in the sleep stages were provoked
sing brief tone pulses or clicks, the EEG frequency rose, but
he MFV remained low or even decreased for a few seconds
efore rising to the earlier level.
O2 reactivity during normal sleep
O2 retention by holding one’s breath or CO2 stimulation will
ead to a vessel dilatation of the cerebral resistance vessels
nd to a decrease of vascular resistance. Therefore, the rel-
tive CO2 reactivity can be deﬁned as the percentage of FV
hange per percentage of mmHg CO2 change. Although the
O2 test is used as a matter of routine [41,42] and although
pproximately more than 30% of all cerebral ischemias occur
t night time, so far little is known about CO2 reactivity
uring normal sleep. We, therefore, tried to perform a CO2
timulation during sleep in healthy subjects. During 19 nights
he authors [Klingelhöfer J et al., unpublished data] were
ble to evaluate on 106 CO2 stimulation periods. In order
o be admitted into evaluation, the healthy subjects had
Cerebral blood ﬂow velocity in sleep 279
Figure 6 Original recording of the left MCA of a 23-year-old
sleeping healthy subject during CO2 stimulation: original enve-
Figure 7 Changes in cerebral vascular reactivity from wake
to sleep. The cerebral vascular reactivity to CO2 from wake to
NREM sleep is reduced in each individual. Open symbols: indi-
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ilope curve, course of MFV, end-expiratory CO2 concentration.
The increase of velocity during CO2 stimulation is clearly visible
(according to [Kingelhöfer J et al., unpublished data]).
to reach at least an end-expiratory CO2 concentration of
more than 50mmHg. They also had to be able to tolerate
a CO2 accumulation period for a minimum of 90 s. Fig. 6
shows an original recording of the left MCA of a 23-year-old
subject during sleep. The topmost recording demonstrates
the original envelope curve, the middlemost the course of
MFV and the lowermost the CO2 concentration during CO2
stimulation. The increase of velocity is clearly visible. From
these data the authors calculated the relative CO2 reactivity
during different sleep stages for the whole healthy collec-
tive. The results show that CO2 stimulation presented no
signiﬁcant differences in light, slow wave and REM sleep
as compared to the waking state in healthy subjects. The
authors concluded that cerebrovascular CO2 reactivity is
maintained during normal sleep. In healthy subjects no sig-
niﬁcant differences as compared to the waking state have
been revealed. During CO2 stimulation in healthy sleepers
an increase of mean EEG frequencies in slow wave sleep has
been explained as a sign of growing activity within an arousal
reaction.
A second study examining CO2 reactivity in normal sleep
was accomplished by Meadows et al. [43,44]. The authors
investigated the effects of stable stage III/IV NREM sleep on
the CBF response to CO2 using TCD to determine MCA veloc-
ity as an index of CBF [43,45]. Meadows et al. determined
that, in normal human subjects, hypercapnic cerebral vas-
cular reactivity is reduced by 70% compared to wakefulness
(Fig. 7). The authors concluded that this marked reduction
in cerebral vascular reactivity during sleep indicates that
the regulation of CBF is signiﬁcantly altered compared with
wakefulness. The functional advantage of such a reduction
in the sleep-related cerebral vascular reactivity could not
be explained by the authors.
Spontaneous hemodynamic behavior during
normal sleep and sleep transitions
characterized with near-infrared spectroscopy
In a current study Näsi et al. [46] carried out 30 all-
night sleep measurements with combined near-infrared
o
d
a
aidual values; solid symbols: group mean values (according to
45]).
pectroscopy (NIRS) and polysomnography to investigate
pontaneous hemodynamic behavior in slow wave sleep com-
ared to light sleep and REM sleep. Their results indicated
hat slow spontaneous cortical and systemic hemodynamic
ctivity was reduced in slow wave sleep compared to
ight sleep, REM sleep and wakefulness. This behavior was
xplained by neuronal synchronization observed in electro-
hysiological studies of slow wave sleep and a reduction in
utonomic nervous system activity. Also, sleep stage transi-
ions were asymmetric, so that the slow wave sleep-to-light
leep and light sleep-to-REM sleep transitions, which are
ssociated with an increase in the complexity of cortical
lectrophysiological activity, were characterized by more
ramatic hemodynamic changes than the opposite transi-
ions. Thus, it appeared to the authors that while the onset
f slow wave sleep and termination of REM sleep occurred
nly as gradual processes over time, the termination of slow
ave sleep and onset of REM sleep may be triggered more
bruptly by a particular physiological event or condition.
athophysiology, cerebral hemodynamics and
BF in sleep apnea syndrome
ll sleep apnea syndromes — whether of the central, the
bstructive, or the mixed type — are characterized by a dis-
rder of breathing during sleep. For diagnostic purposes,
pnea is deﬁned as a cessation of airﬂow at the nose and
outh lasting at least 10 s [47]. The diagnosis of SAS is
ade when at least 30 apneic episodes are observed dur-
ng REM and NREM stages over 7 h of nocturnal sleep. Some
f the apneic episodes must appear in a repetitive sequence
uring NREM sleep [48]. Sleep apnea syndromes have been
ssociated with medical complications such as pulmonary
nd arterial hypertension, cardiovascular disease, excessive
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aytime sleeping, fatigue and morning headache [48,49], as
ell as increased risk of cerebral infarction [50—54].
The etiology of SAS remains equivocal, but several mech-
nisms (e.g., instability of central respiratory regulation,
eduction in the responsiveness of medullary chemorecep-
ors and relaxation of the upper airway musculature during
leep) have been proposed as factors in the genesis of noc-
urnal apnea phases [55—60]. Longobardo et al. [56] believe
hat an increase in circulation time between receptors in
he brainstem respiratory centers and controlled alveolar
entilation is the cause of periodic cessation of breathing.
ecause apnea is accompanied by hypoxia and hypercap-
ia and pCO2 and perivascular pH are major regulatory
eterminants of CBF and ﬂow velocity, changes in cere-
ral hemodynamics are to be expected in patients with
AS [35,41,42,61]. These theoretic considerations have been
onﬁrmed by a limited number of studies. Meyer et al.
62] performed CBF measurements during daytime sleep-
ng and waking states in 13 patients with narcolepsy and
with SAS. In the waking state, brainstem, cerebellar and
ihemispheric ﬂow were below normal in both patient
roups. After sleep onset, CBF decreased further; maxi-
um changes of regional ﬂow values were seen in brainstem
egions, indicating a critically reduced brainstem functional
ctivity during sleep in SAS. Alterations of ﬂow velocities
uring apnea-associated changes of CO2 were also reported
n obstructive SAS [63].
BF velocity during sleep apnea syndrome
ow that several studies have shown that transcranial
oppler sonography is a useful method for long-term and
n-line monitoring of dynamic changes in cerebral perfu-
ion during sleep, researchers have begun using TCD for
he assessment of perfusion changes in pathological sleep
onditions. Various studies have been performed to assess
erebral ﬂow velocity changes during nocturnal apneic
pisodes in patients with SAS. Siebler et al. [64] were
he ﬁrst to observe a cerebral ﬂow velocity increase dur-
ng nocturnal apneic phases in a patient with obstructive
AS and their ﬁndings have since been conﬁrmed by vari-
us independent work groups in larger numbers of patients
65—67]. Fischer et al. [34], who compared the MFV changes
n SAS patients with those of a comparable control group,
bserved lower MFV values in SAS patients during wake-
ulness, NREM sleep and REM sleep than in normals. They
herefore concluded that altered cerebral perfusion occurs
n SAS patients.
However, a sleep stage-correlated CBF velocity assess-
ent in SAS patients and normal control subjects
etermined that the course of CBF velocity changes in
pneic patients during night sleep were comparable to
hose observed in healthy control subjects. These ﬁnd-
ngs indicate that the general pattern of cerebral perfusion
hanges associated with sleep remains preserved in SAS and
hey contradict the hypothesis of the existence of cere-
ral hypoperfusion in SAS [65,66]. Klingelhöfer et al. [66]
bserved MFV increases of 19—219%, reaching a maximum
n REM sleep, during apneic episodes in 6 patients with SAS
age: 34—55 years, mean age: 49 years) (Fig. 8). There was
lso a signiﬁcant increase in blood pressure (12.5—83.1%)
[
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uring apneic episodes. A multiple linear regression anal-
sis revealed that the ﬂow velocity increase was not only
ttributable to the blood pressure increase alone, but was
igniﬁcantly linked to apnea.
Siebler and Nachtmann [67] compared the ﬂow velocity
esponses during apneic episodes in SAS patients with those
bserved during arbitrary apnea in healthy control subjects.
hey detected comparable MFV increases in both groups and
oncluded that cerebral CO2 reactivity is preserved in SAS.
lingelhöfer et al. [66] also observed normal CO2 reactiv-
ty (4.4± 1.2%) in SAS patients during wakefulness, but the
eactivity values increased signiﬁcantly during sleep stages
and II and reached a maximum during REM sleep with rises
f CO2 reactivity up to three times the waking values. The
uthors interpreted the increase in CO2 reactivity during
leep as hypersensitivity of intracranial CO2 or pH recep-
ors in SAS patients and attributed this to a possible disorder
f the central catecholaminergic and cholinergic systems in
AS. They presume that the marked ﬂow velocity ﬂuctua-
ions during apneic episodes and the associated changes in
essel wall tension place a chronic strain on the cerebral
lood vessels, thereby promoting the development of micro-
nd macroangiopathy. This, among other factors, could be
reason for the increased incidence of cerebral ischemia in
atients with SAS.
In addition to the apnea-associated increase in CBF
elocity, which most authors attribute to apnea-related
ypercapnia [64—67], it is also notable that a rapid nor-
alization of ﬂow velocity occurs at the end of each apneic
pisode. Hajak et al. [65] demonstrated in 10 patients (mean
ge: 37 years) that, in addition to its connection with the
estoration of breathing and the associated occurrence of
ormocapnia, this ﬂow velocity reduction is also regularly
ssociated with the occurrence of EEG arousal or movement
rousal. Because arousals represent a type of neuronal acti-
ation, the authors concluded that this indicates a direct
euronal inﬂuence on ﬂow velocity during apneic episodes.
Franklin [68] compared cerebral hemodynamics in
bstructive sleep apneas and central sleep apneas. Cere-
ral and cardiovascular changes display a different pattern
uring central and obstructive sleep apneas. By means of
heir study they revealed that the CBF velocity according
o TCD increases during an obstructive apnea and decreases
fter apnea termination concomitant with changes in arte-
ial pressure. Their interpretation of the results was: the
hanges in cerebral circulation during obstructive apneas
ould be an immediate effect of rapid changes in blood
ressure because cerebral autoregulation is overridden. The
pposite pattern was seen during a central apnea, with
decrease in CBF velocity during apnea and an increase
fter apnea termination (Fig. 9). Changes during obstructive
pneas are probably hazardous, with adverse cardiovascu-
ar effects including stroke. This may not be the case during
entral apneas, as Cheyne—Stokes respiration with central
pneas is a result of an underlying disorder such as heart
ailure and stroke and is not a disease entity in itself.
Contrary to every study using TCD during obstructive
leep apnea [65—67,69,70], Netzer et al. reported in 1998
71] that the CBF velocity declined during 80% of obstructive
leep apneas. They also recorded a decline in CBF veloc-
ty during central apnea but only in 14% of central apneas,
hich contradicts the studies by Franklin et al. [68,72],
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Figure 8 Changes in ﬂow velocity (FV) and mean ﬂow velocity (MVF) of the right middle cerebral artery (MCA), and changes in
blood pressure (BP) and end-tidal CO2 concentration (pCO2) in a 35-year-old man with severe sleep apnea syndrome (A, E) during
the wakeful state and (B—D) during different sleep stages. Due to methodological reasons, the measured rise in pCO2 is too low
after some apneic episodes. In these cases, expiration of air did not take place exclusively through the nose, where the sensor for
the end-tidal pCO2 determination was located. These apneic episodes were excluded from the CO2 reactivity calculations. FV: ﬂow
g to
v
p
a
a
v
l
o
u
c
tvelocity; BP: blood pressure; MFV: mean ﬂow velocity (accordin
which reports a consistently low CBF velocity during central
apnea. The reason for these contradictory results is unclear
and the authors do not discuss their ﬁndings in comparison
with others.
The cerebral vascular reactivity to hypercapnia in
patients with obstructive sleep apnea syndrome (OSAS) was
investigated by Diomedi et al., 1998 [73] and Placidi et al.,
1998 [74] to evaluate the inﬂuence of hemodynamic changes
caused by OSAS. They studied cerebral vascular reactivity
to hypercapnia calculated by means of the breath holding
index. The investigation was performed in the early morn-
ing, soon after awakening and in the late afternoon. OSAS
patients showed signiﬁcantly lower breath holding index
values with respect to controls both in the morning (0.57
c
p
h[66]).
s. 1.40; p < 0.0001) and in the afternoon (1.0 vs. 1.51;
< 0.0001). In patients, breath holding index values in the
fternoon were signiﬁcantly higher than in the morning. The
uthors concluded that the data demonstrate a diminished
asodilator reserve in obstructive OSAS patients, particu-
arly evident in the morning. This reduction of the possibility
f cerebral vessels to adapt functionally in response to stim-
lation could be linked to hyposensitivity of cerebrovascular
hemoreceptors after the continuous stress caused by noc-
urnal hypercapnia.Droste et al. [75] studied the potential effect of
ontinuous positive airway pressure (CPAP) on cerebral
erfusion. They investigated 23 patients with OSAS and 16
ealthy young adults in the waking state. As compared with
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RFigure 9 Outline of the hemodynamic pattern du
ormal breathing CBF velocity of MCA and pCO2 remained
nchanged during CPAP. Systolic and diastolic blood pressure
ncreased slightly by 1.2mmHg and 1.1mmHg, respectively.
erebrovascular reactivity did not differ in the two groups.
rom their ﬁndings the authors concluded that nasal
PAP of 9 cmH2O is a safe treatment with respect to the
aintenance of CBF. The study gives further evidence for
he autoregulation’s capacity to maintain CBF velocity
onstant during different levels of intrathoracic pressure
nd different cerebral perfusion pressures.
Another group of scientists [76] analyzed whether
ncreasing levels of CPAP may affect cerebral hemodynam-
cs, assessed by TCD in normal humans. They found that
ven low levels of CPAP delivered through a mouthpiece in
wake, young volunteers led to a decrease in CBF velocity,
easured by TCD. This fall in CBF velocity was associated
ith hypocapnia and with an increase in both cerebrovascu-
ar resistance and anxiety due to breathing against positive
ressure.
In a recent study Furtner et al. [63] investigated CBF
elocity changes and vascular compliance in patients with
SAS using TCD and cerebral pulse transit time. Cerebrovas-
ular reactivity was assessed by calculation of apnea and
ypopnea-related CBF velocity changes. Arterial compliance
as characterized by cerebral pulse transit time derived
rom phase difference analysis between ECG and TCD
ignals. Sleep time was dichotomized into periods with high
ensity of consecutive respiratory events vs. periods with
ow density of consecutive respiratory events. TCD measure-
ents of CBF velocity showed a regular, undulating pattern
ith ﬂow minima immediately before apneas or hypopneas
nd maxima closely after their termination, reciprocally
o peripheral O2 saturation. CBF velocity reactivity was
igniﬁcantly diminished in consecutive respiratory eventsobstructive and central apnea (according to [68]).
ompared to non-consecutive respiratory event periods. The
uthors discussed severe disturbances of cerebrovascular
eactivity in OSAS patients and interpreted their data as a
ign of loss of vasoreactivity and increase of arterial stiff-
ess.
onclusion
he combined long-term recordings of intracranial ﬂow pat-
erns and polysomnography constitute an important method
or evaluating dynamic aspects of brain function and cere-
ral perfusion during sleep. Numerous studies concerning
his scientiﬁc ﬁeld using this technique have contributed to
better understanding of the physiology of the normal sleep
nd the pathophysiology of sleep disorders as well as that of
octurnal stroke.
eferences
[1] Krueger JM, Rector DM, Roy S, Van Dongen HPA, Belenky G,
Panksepp J. Sleep as a fundamental property of neuronal
assemblies. Nat Rev Neurosci 2008;9:910—9.
[2] Rechtschaffen A, Kales A. A manual for standardized terminol-
ogy, techniques and scoring system for sleep stages of human
subjects. In: US public health service. Washington, DC: US Gov-
ernment Printing Ofﬁce; 1968.
[3] Sakai F, Meyer JS, Karacan I, Derman S, Yamamoto M. Nor-
mal human sleep: regional cerebral hemodynamics. Ann Neurol
1980;17:47l—8l.[4] Gozukirmizi E, Meyer JS, Okabe T, Amano T, Mortel K, Kara-
can I. Cerebral blood ﬂow during paroxysmal EEG activation
induced by sleep in patients with complex partial seizures.
Sleep 1982;5:329—42.
[[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[Cerebral blood ﬂow velocity in sleep
[5] Kennedy C, Gillin JC, Mendelson W, Suda S, Miyaoka M, Ito M,
et al. Local cerebral glucose utilization in nonrapid eye move-
ment sleep. Nature 1982;297:325—7.
[6] Heiss WD, Pawlik G, Herholz K, Wagner R, Wienhard K. Regional
cerebral glucose metabolism in man during wakefulness, sleep,
and dreaming. Brain Res 1985;327:362—6.
[7] Meyer JS, Ishikawa Y, Hata T, Karacan I. Cerebral blood ﬂow
in normal and abnormal sleep and dreaming. Brain Cogn
1987;6:266—94.
[8] Meyer JS, Amano T, Karacan I, Derman S, Hartse K, Nakajima
S. Changes in LCBF measured by CT scan during REM and non-
REM human sleep. J Cereb Blood Flow Metab I 1981;(Suppl.
1):465—6.
[9] Madsen PL, Schmidt JF, Wildschiødtz G, Friberg L, Holm S,
Vorstrup S, et al. Cerebral oxygen metabolism and cerebral
blood ﬂow in humans during deep and rapid-eye-movement
sleep. J Appl Physiol 1991;70:2597—601.
[10] Zoccoli G, Walker AM, Lenzi P, Franzini C. The cerebral cir-
culation during sleep: regulation mechanisms and functional
implications. Sleep Med Rev 2002;6(6):443—55.
[11] Buchsbaum MS, Gillin JC, Wu J, Hazlett E, Sicotte N, Dupont
RM, et al. Regional cerebral glucose metabolic rate in human
sleep assessed by positron emission tomography. Life Sci
1989;45:1349—56.
[12] Maquet P, Dive D, Salmon E, Sadzot B, Franco G, Poirrier R,
et al. Cerebral glucose utilization during sleep-wake cycle in
man determined by positron emission tomography and [18F]2-
ﬂuoro-2-deoxy-D-glucose method. Brain Res 1990;513:136—43.
[13] Reivich M, Isaacs G, Evarts E, Kety S. The effect of slow wave
sleep and REM sleep on regional cerebral blood ﬂow in cats. J
Neurochem 1968;15:301—6.
[14] Lenzi P, Cianci T, Guidalotti PL, Leonardi GS, Franzini C. Brain
circulation during sleep and its relation to extracerebral hemo-
dynamics. Brain Res 1987;415:14—20.
[15] Madsen PL, Holm S, Vorstrup S, Friberg L, Wildschiødtz
G. Human regional cerebral blood ﬂow during rapid-eye-
movement sleep. J Cereb Blood Flow Metab 1991;11:502—7.
[16] Ingvar DH, Rosen I, Johannesson G. EEG related to
cerebral metabolism and blood ﬂow. Pharmakopsychiatry
1979;12:200—9.
[17] Massimini M, Tononi G, Huber R. Slow waves, synaptic plas-
ticity and information processing: insights from transcranial
magnetic stimulation and high density EEG experiments. Eur
J Neurosci 2009;29(9):1761—70.
[18] Kubota Y, Takasu NN, Horita S, Kondo M, Shimizu M, Okada T,
et al. Dorsolateral prefrontal cortical oxygenation during REM
sleep in humans. Brain Res 2011;1389:83—92.
[19] Meyer JS. Regulation of cerebral hemodynamics in health and
disease. Eur Neurol 1983;22(Suppl. 1):47—60.
[20] Uchida-Ota M, Tanaka N, Sato H, Makia. A intrinsic correlations
of electroencephalography rhythms with cerebral hemodynam-
ics during sleep transitions. NeuroImage 2008;42:357—68.
[21] Raichle ME, Grubb Jr RL, Gado MH, Eichling JO, Ter-Pogossian
MM. Correlation between regional cerebral blood ﬂow and
oxidative metabolism. In vivo studies in man. Arch Neurol
1976;33:523—6.
[22] Mazzilotta JC, Phelps ME, Miller J, Kuhl DE. Tomographic
mapping of human cerebral metabolism: normal unstimulated
state. Neurology 1981;31:503—16.
[23] Phelps ME, Kuhl DE, Mazziotta JC. Metabolic mapping of the
brain’s response to visual stimulation: studies in humans. Sci-
ence 1981;211:1445—8.
[24] Kuschinsky W, Wahl M. Local chemical and neurogenic
regulation of cerebral vascular resistance. Physiol Rev
1978;58:656—89.
[25] Sokoloff L. Relationships among local functional activity,
energy metabolism, and blood ﬂow in the central nervous sys-
tem. Fed Proc 1981;40:2311—6.
[283
26] Aaslid R. Visually evoked dynamic blood ﬂow response on the
human cerebral circulation. Stroke 1987;18(4):771—5.
27] Conrad B, Klingelhöfer J. Dynamics of regional blood ﬂow for
various visual stimuli. Exp Brain Res 1989;77:437—41.
28] Aaslid R, Lindegaard KF, Sorteberg W, Nomes H. Cere-
bral autoregulation dynamics in humans. Stroke 1989;20:
45—52.
29] Klingelhöfer J, Matzander G, Sander D, Schwarze JJ, Boecker H,
Bischoff C. Assessment of functional hemispheric asymmetry by
bilateral simultaneous cerebral blood ﬂow velocity monitoring.
J Cereb Blood Flow Metab 1997;17:577—85.
30] Lassen NA. Measurement of regional cerebral blood ﬂow in
humans with single photonemitting radioisotopes. In: Sokoloff
L, editor. Brain imaging and brain function. New York: Raven
Press; 1985. p. 9—20.
31] Madsen PL, Schmidt JF, Holm S, Vorstrup S, Lassen NA, Wild-
schiodtz G. Cerebral oxygen metabolism and cerebral blood
ﬂow in man during light sleep (stage 2). Brain Res 1991;557:
217—20.
32] Phelps ME, Mazziotta JC, Huang SC. Review: study of cerebral
function with positron computed tomography. J Cereb Blood
Flow Metab 1982;2:113—62.
33] Fischer AQ, Taonruna MA, Akhtar B, Chaudhary BA. The effect
of sleep on intracranial hemodynamics: a transcranial Doppler
study. J Child Neurol 1991;6:155—8.
34] Fischer AQ, Chaudhary BA, Taormina MA, Akhtar B. Intracranial
hemodynamics in sleep apnea. Chest 1992;102:1402—6.
35] Markwalder TM, Grolimund P, Seiler RW, Roth F, Aaslid R. Depen-
dency of blood ﬂow velocity in the middle cerebral artery
on end-tidal carbon dioxide partial pressure — a transcranial
ultrasound Doppler study. J Cereb Blood Flow Metab 1984;4:
368—72.
36] Droste DW, Berger W, Schuler E, Krauss JK. Middle cere-
bral artery blood ﬂow velocity in healthy persons during
wakefulness and sleep: a transcranial Doppler study. Sleep
1993;16:603—9.
37] Hajak G, Klingelhöfer J, Schulz-Varszegi M, Matzander G, Con-
rad B, Ruther E. New views into the dynamic changes of
cerebral blood ﬂow during sleep. In: Home J, editor. Sleep’90.
Bochum: Pontenagel Press; 1990. p. 78—81.
38] Hajak G, Klingelhöfer J, Schulz-Varszegi M, Matzander G,
Sander D, Conrad B, et al. Relationship between cerebral blood
ﬂow velocities and cerebral electrical activity in sleep. Sleep
1994;17:11—9.
39] Klingelhöfer J, Hajak G, Matzander G, Schulz-Varszegi M,
Sander D, Rüther E, et al. Dynamics of cerebral blood ﬂow
velocities during normal human sleep. Clin Neurol Neurosurg
1995;97:142—8.
40] Droste DW, Krauss JK, Berger W, Schuler E, Brown MM.
Rhytmic oscillations with a wavelength of 0.5—2min in tran-
scranial Doppler recordings. Acta Neurol Scand 1994;90(2):
99—104.
41] Ringelstein EB, Sievers C, Ecker S, Schneider PA, Otis SM. Nonin-
vasive assessment of CO2-induced cerebral vasomotor response
in normal individuals and patients with internal carotid artery
occlusions. Stroke 1988;19:963—9.
42] Widder B, Paulat K, Hackspacher J, Mayr E. Transcranial
Doppler CO2-test for the detection of hemodynamically criti-
cal carotid artery stenoses and occlusions. Eur Arch Psychiatry
Neurol Sci 1986;236:162—8.
43] Meadows GE, Dunroy HM, Morell MJ, Corﬁeld DR. Hyper-
capnic cerebral vascular reactivity is decreased, in human,
during sleep compared with wakefulness. J Appl Physiol
2003;94:2197—202.44] Meadows GE, O’Driscoll DM, Simonds AK, Morell MJ, Cor-
ﬁeld DR. Cerebral blood ﬂow response to isocapnic hypoxia
during slow-wave sleep and wakefulness. J Appl Physiol
2004;97:1343—8.
2[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[84
45] Corﬁeld DR, Meadows GE. Control of cerebral blood ﬂow
during sleep and the effects of hypoxia. Adv Exp Med Biol
2006;588:65—73.
46] Näsi T, Virtanen J, Noponen T, Toppila J, Salmi T, Ilmoniemi
RJ. Spontaneous hemodynamic oscillations during human sleep
and sleep stage transitions characterized with near-infrared
spectroscopy. PLoS ONE 2011;10:e25415.
47] Guilleminault C, Eldridge FL, Simmon FB, Dement WC. Sleep
apnea syndrome: can it induce hemodynamic changes? West J
Med 1975;123:7—16.
48] Guilleminault C, Tilkian A, Dement WC. The sleep apnea syn-
dromes. Annu Rev Med 1976;27:465—84.
49] Guilleminault C. Clinical features and evaluation of obstruc-
tive sleep apnea. In: Kryger MH, Roth T, Dement WC, editors.
Principles and practice of sleep medicine. Philadelphia: WB
Saunders; 1989.
50] Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet
1985;2(8468):1325—6.
51] Bassetti C, Aldrich MS, Chervin RD, Quint D. Sleep apnea in
patients with transient ischemic attack and stroke: a prospec-
tive study of 59 patients. Neurology 1996;47(5):1167—73.
52] Silvestrini M, Rizzaro B, Placidi F, BarutTaldi R, Bianconi A,
Diomedi M. Carotid artery wall thickness in patients with
obstructive sleep apnea syndrome. Stroke 2002;33(7):1782—5.
53] Nachtmann A, Stang A, Wang YM, Wondzinski E, Thilmann
AF. Association of obstructive sleep apnea and stenotic
artery disease in ischemic stroke patients. Atherosclerosis
2003;169(2):301—7.
54] Hsieh SW, Lai CL, Liu CF, Hsu CY. Obstructive sleep apnea linked
to wake-up strokes. J Neurol 2012;4.
55] Onal E, Lopata M. Periodic breathing and the pathogenesis of
occlusive sleep apneas. Am Rev Respir Dis 1982;126:667—80.
56] Longobardo GS, Gothe B, Goldman MD, Cherniack MS. Sleep
apnea considered as a control system instability. Respir Physiol
1982;50:311—33.
57] Patrick GB, Strohl KP, Rubin SB, Altose MD. Upper airway and
diaphragm muscle responses to chemical stimulation and load-
ing. J Appl Physiol 1982;53:1133—7.
58] Strohl KP, Saunders NA, Sullivan CE. Sleep apnea syndromes.
In: Saunders NS, Sullivan CE, editors. Sleep breathing. New
York/Basel: Marcel Decker; 1984.
59] Ayalon L, Peterson S. Functional central nervous system imag-
ing in the investigation of obstructive sleep apnea. Curr Opin
Pulm Med 2007;13(6):479—83.
60] Desseilles M, Dang-Vu T, Schabus M, Sterpenich V, Maquet P,
Schwartz S. Neuroimaging insights into the pathophysiology of
sleep disorders. Sleep 2008;31(6):777—94.
61] Kirkham FJ, Padayachee TS, Parsons S, Seargeant LS, House
FR, Gosling RG. Transcranial measurement of blood velocities
in the basal cerebral arteries using pulsed Dopple ultra-
sound: velocity as an index of ﬂow. Ultrasound Med Biol
1986;12:15—21.
[J. Klingelhöfer
62] Meyer JS, Sakai F, Karacan I, Derman S, Yamamoto M. Sleep
apnea, narcolepsy, and dreaming: regional cerebral hemody-
namics. Ann Neurol 1980;7:479—85.
63] Furtner M, Staudacher M, Frauscher B, Brandauer E,
Esnaola y Rojas MM, Gschliesser V, et al. Cerebral vasore-
activity decreases overnight in severe obstructive sleep
apnea syndome: a study of cerebral hemodynamics. Sleep
2009;10:875—81.
64] Siebler M, Daffertshofer M, Hennerici M, Freund HJ. Cerebral
blood ﬂow velocity alterations during obstructive sleep apnea
syndrome. Neurology 1990;40:1461—2.
65] Hajak G, Klingelhöfer J, Schulz-Varszegi M, Sander D, Rüther
E. Sleep apnea syndrome and cerebral hemodynamics. Chest
1996;110:670—9.
66] Klingelhöfer J, Hajak G, Sander D, Schulz-Varszegi MC, Ruther
E, Conrad C. Assessment of intracranial hemodynamics in sleep
apnea syndrome. Stroke 1992;23:1427—33.
67] Siebler M, Nachtmann A. Cerebral hemodynamics in obstructive
sleep apnea. Chest 1993;103:1118—9.
68] Franklin KA. Cerebral haemodynamics in obstructive sleep
apnoea and Cheyne—Strokes respiration. Sleep Med Rev
2002;6(6):429—41.
69] Rieke K, Poceta JA, Mitler MM, Ley LR, Torruella AK, Adams HP,
et al. Continuous blood ﬂow velocity measurements in obstruc-
tive sleep apnoea syndrome. J Neuroimaging 1992;2:202—7.
70] Bålfors EM, Franklin KA. Impairment of cerebral perfusion dur-
ing obstructive sleep apnoeas. Am J Respir Crit Care Med
1994;150:1587—91.
71] Netzer N, Werner P, Jochums I, Lehmann M, Strohl KP. Blood
ﬂow of the middle cerebral artery with sleep-disordered
breathing: correlation with obstructive hypopneas. Stroke
1998;29:87—93.
72] Franklin KA, Sandström E, Johansson G, Bålfors EM. Hemo-
dynamics, cerebral circulation and oxygen saturation in
Cheyne—Strokes respiration. J Appl Physiol 1997;83:1184—91.
73] Diomedi M, Placidi F, Cupini LM, Bernardi G, Silvestrini. Cere-
bral hemodynamic changes in sleep apnea syndrome and effect
of continuous positive airway pressure treatment. Neurology
1998;51:1051—6.
74] Placidi F, Diomedi M, Cupini LM, Bernadi G, Silvestrini
M. Impairment of daytime cerebrovascular reactivity in
patients with obstructive sleep apnoea syndrome. J Sleep Res
1998;7:288—92.
75] Droste DW, Lüdemann P, Anders F, Kemény V, Thomas M, Krauss
JK, et al. Middle cerebral artery blood ﬂow velocity, end-tidal
pCO2 and blood pressure in patients with obstructive sleep
apnea and in healthy subjects during continuous positive air-
way pressure breathing. Neurol Res 1999;21:737—41.76] Scala R, Turkington PM, Wanklyn P, Bamford J, Elliot MW.
Effects of incremental levels of continuous positive airway
pressure on cerebral blood ﬂow velocity in healthy adult
humans. Clin Sci 2003;104:633—9.
